SXTP News and Press, 60 Degrees Pharmaceuticals Inc.

A look at the top 10 most actives in the United States Actelis Networks Inc (ASNS) rose 47.6% to $0.555 on volume of 375,381,115 shares KALA BIO Inc. (KALA) rose 24.2% to $0.3649 on volume of 287,198,851 shares Direxion Small Cap Bear 3X (TZA) rose 0.7% to $6.84 on volume of 154,932,634 sha...

All three patients enrolled in study have been cured, confirming high cure rate of  tafenoquine in immunosuppressed patients, as reported by Yale in a 2024 publication Company calls for existing babesiosis treatment guidelines to be reviewed in light of the new data WASHINGTON, March 11...

GoodRx to offer prescription savings of up to 30% for ARAKODA ® ( tafenoquine ) Collaboration designed to lower patient out-of-pocket costs and expand the reach of Company’s marketing strategy Partnership will improve the affordability of ARAKODA at over 70,000 pharmacies nati...

WASHINGTON, Jan. 28, 2026 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc.  (NASDAQ: SXTP; SXTPW) (“60 Degrees Pharma” or the “Company”), a pharmaceutical company focused on developing new medicines for vector-borne disease, today announced it has exercised...

A look at the top 10 most actives in the United States IO Biotech Inc. (IOBT) rose 131.3% to $0.4801 on volume of 473,914,684 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) fell 0.5% to $1.96 on volume of 269,649,840 shares Healthcare Triangle Inc. (HCTI) fell 7.7% to $0.3693 on ...

A look at the top 10 most actives in the United States IO Biotech Inc. (IOBT) rose 148.0% to $0.5148 on volume of 418,624,334 shares Healthcare Triangle Inc. (HCTI) fell 7.9% to $0.3683 on volume of 261,071,767 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) fell 0.5% to $1.96 on ...

Partnership adds a travel-focused consumer telehealth platform to the ARAKODA ® marketing strategy, offering a new convenience to people planning travel to malaria-endemic regions of the world ARAKODA is the only FDA-approved, broad spectrum, once-weekly malaria prevention option for inter...

2026-01-15 08:16:11 ET More on 60 Degrees Pharmaceuticals 60 Degrees Pharmaceuticals GAAP EPS of -$0.66 misses by $0.20, revenue of $0.44M beats by $0.29M Seeking Alpha’s Quant Rating on 60 Degrees Pharmaceuticals Historical earnings data for 60 Degrees Pharma...

WASHINGTON, Jan. 15, 2026 (GLOBE NEWSWIRE) -- 60 Degree Pharmaceuticals, Inc. NASDAQ: SXTP; SXTPW) (“60 Degrees Pharma” or the “Company”), a pharmaceutical company focused on developing new medicines for vector-borne disease, today announced that it will effect a one-f...

Further validates continuation of the B-FREE Study to evaluate the efficacy and safety of ARAKODA ® ( tafenoquine ) for treatment of chronic babesiosis Data support theory among specialists that Babesia infection may prolong recovery times in patients with chronic fatigue WASHINGTON, ...